Vitazi.AI
AI-Powered Diagnostic Imaging
Tramway launched Vitazi.ai in July of 2021. An internally incubated startup, Vitazi will deliver an artificial intelligence platform to the medical device market that will enable customers to apply consistent and industry leading artificial intelligence analytics to their data sets to improve physician efficiency and diagnostic accuracy. Vitazi is committed to providing trusted and interoperable artificial intelligence to medical images. The company’s first partner is VisionQuest, an Albuquerque company which has licensed its retinal imaging artificial intelligence software and FDA approved image quality analyzer to Vitazi.
Latest Vitazi.AI News
VSP Vision Innovation Challenge Winners Revealed at Vision Expo West 2025
LAS VEGAS—Vision Expo West, produced by RX and The Vision Council, in collaboration with VSP Vision, a leader in health-focused vision care, and MATTER, the premier health care incubator and…
Vitazi.ai Announces Partnership with Eye Associates of New Mexico to Advance AI-Powered Retinal Screening
SANTA FE, N.M., Feb. 12, 2025 /PRNewswire/ — Vitazi.ai, Inc., a key leader in Oculomics, is pleased to announce an agreement with Eye Associates of New Mexico, the largest ophthalmology…
Vitazi.ai Creates a Platform to Deliver Artificial Intelligence to Improve Physician Efficiency and Diagnostics Accuracy
Vitazi.ai is reimagining image-based diagnostics so providers can gain higher quality, real time & trustable health insights. October 8, 2021 Albuquerque, New Mexico — Today Tramway Venture Partners…